Table 1.
Patient characteristics before and after the implementation of the DITSMI model
| N = 83 patients | Before | After | p |
|---|---|---|---|
| Mean age | 49 (SD 11.8) | 52 (SD12.7) | |
| Mean duration of care history | 21 (SD 8.9) | 24 (SD 8.3) | |
| % men | 69% | 69% | |
| % partner | 18% | 18% | |
| Developmental disorder (autism, PDD-NOS ADHD) | 6% | 16% | 0.028 |
| Psychosis NOS | 8% | 19% | 0.043 |
| Schizophrenia | 53% | 36% | 0.019 |
| Schizoaffective disorder | 8% | 10% | 0.773 |
| Bipolar disorder | 8% | 2% | 0.031 |
| Depressive disorder | 5% | 4% | 0.731 |
| Personality disorder | 4% | 2% | 0.173 |
| PTSD | 1% | 5% | 0.093 |
| Mild or borderline intellectual functioning | 4% | 18% | 0.002 |
| Pedophilia | – | 1% | – |
| Substance-abuse | 21% | 16% | 0.419 |
| % of resident patients | 100% | 60% | <0.001 |
| Patients’ mean (SD) overall length of stay in years | 20.2 (8.7) | 22.6 (9.0) | <0.001 |
| Patients’ mean (SD) length of stay in years since 2000 | 13.6 (7.8) | 15.4 (7.2) | <0.001 |
| First-generation antipsychotic medication | 44% | 25% | 0.010 |
| Second-generation antipsychotic medication | 56% | 75% | 0.009 |
| Clozapine | 25% | 39% | 0.030 |
| Anticholinergic medication use | 35% | 19% | 0.023 |
| BMI (mean, SD) | 27.7 (5.0) | 30.4 (5.3) | 0.323 |
| Side effects | 38% | 23% | 0.028 |
| Diagnosis changed | 49% | ||
| Treatment proposal changed | 67% | ||
| Medication changed | 67% | ||
| Somatic comorbidity | 53% | ||
| Was provided psychotherapy | 16% | ||
| Relapse as defined by coercive measure or transfer to intensive care wards | 15% | ||
| Discharge | 35% | ||
| Deceased | 7% |
Abbreviations: PDD-NOS, Pervasive Developmental Disorder Not Otherwise Specified; ADHD, attention deficit hyperactivity disorder; Psychosis NOS, Psychosis Not Otherwise Specified BMI, body mass index; DITSMI, Diagnose, Indicate, Treat, Severe Mental Illness; PTSD, posttraumatic stress disorder; SD, standard deviation.